Japan home health tech player gets $4.4m

The investment follows Triple W’s JPY500 million Series A round earlier this year, in which 2020 also participated. According to a statement, Triple W plans to close the Series B round next year with JPY1 billion in commitments. Nissay and 2020 closed their commitments early so that the company could continue its growth.

Triple W develops technology-based healthcare solutions aimed principally at the Japanese market, where healthcare is facing a labor shortage coupled with growing demand from the country’s ageing population. It is best known for the DFree device, which uses ultrasound to monitor the bladder and notify incontinent patients when urination is approaching.

As many as 150 nursing facilities across Japan have adopted the DFree device, along with a major hospital in Singapore. Aged care provider Korian is also testing the device at its facilities in Paris, in preparation for introducing it across its European network. Triple W has also been selected as a partner in the Japanese government’s initiative to develop robotics for nursery care.

Triple W previously distributed its technology and services exclusively on a business-to-business model. It plans to begin selling to individual consumers in the near future, in response to growing visibility of the company and its products in the media.

Nissay is currently investing, Nissay Capital No. 7, which closed last year with JPY10 billion in commitments. The firm pursues buy-out, growth capital and early-stage deals involving Japanese technology companies. Recent investments include sensor maker Skydisc and workplace chat app developer Oneteam.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• North Asia
• Early-stage
• Technology
• Healthcare
• Japan
• Nissay Capital
• Foxconn Technology Group
• TMT